ALOX5 variants associated with susceptibility to human pulmonary tuberculosis

F. Herb, Thorsten Thye, Stefan Niemann, E. N. L. Browne, Margaret A. Chinbuah, John O. Gyapong, Ivy Osei, Ellis Owusu‐Dabo, Oliver Werz, Sabine Rüsch–Gerdes,

Human Molecular Genetics · 2007 · 100 citations · 36 references

Abstract

The 5-lipoxygenase (<it>ALOX5</it>)-derived lipid mediators leukotrienes and lipoxins have regulatory functions in inflammation by modulating activities of immune cells and cytokine production. Recently, it was shown in <it>ALOX5</it><it>−/−</it> mice that host control of <it>Mycobacterium tuberculosis</it> is regulated by 5-lipoxygenase (5-LO). <it>ALOX5</it> polymorphisms were genotyped in 1916 sputum-positive patients with pulmonary tuberculosis (TB) from Ghana and in 2269 exposed, apparently healthy controls. Polymorphisms of a variable number of tandem repeats (VNTR) of the <it>ALOX5</it> promoter and of the exonic non-synonymous variant g.760G>A were analysed by fragment length determination and fluorescence resonance energy transfer, respectively, and DNA sequencing. Mycobacterial lineages of >1400 isolates were differentiated biochemically and genetically. Carriers of one variant (<it>n</it> repeats ≠ 5) and one wild-type VNTR allele (<it>n</it> = 5) or of the exonic allele g.760A had a higher risk of TB [<it>P</it><inf>corrected</inf> = 0.026, odds ratio (OR) 1.19 (95% CI 1.04–1.37) and <it>P</it><inf>corrected</inf> = 0.026, OR 1.21 (95% CI 1.04–1.41), respectively]. The association of the exonic variant was stronger in infections caused by the mycobacterial lineage <it>M</it>. <it>africanum</it> West-African 2 [<it>P</it><inf>corrected</inf> = 0.024, OR 1.70; (95% CI 1.2–2.6)]. Determination of haplotypes revealed the strongest associaton with TB for the ‘non-5/760A’ haplotype compared with the ‘non-5/760G’ haplotype (<it>P</it> = 0.003, OR 1.50). Our observation of an association of <it>ALOX5</it> variants with susceptibility to TB contributes evidence of the importance of 5-LO products to the regulation of immune responses to <it>M</it>. <it>tuberculosis</it>.

References

36